<?xml version="1.0" encoding="UTF-8"?>
<p>Another inhibitor, nafamostat, used as an anticoagulant and anti-pancreatitis agent and is approved for the treatment of cystic fibrosis. Nafamostat has mucolytic action and can prevent the deterioration of lung function (
 <xref rid="B49" ref-type="bibr">49</xref>).
</p>
